Annals of Neurology · 2016 · 27 citations · 41 references
MedicineNeurobiologyNeuroscienceMolecular NeuroscienceRegenerative MedicineSignal TransductionNerve RegenerationNerve RepairNervous TissueNeural RegenerationNeurite OutgrowthPeripheral Nerve InjuryDelayed Nerve RepairEpidermal Growth Factor Receptor SignalingMotor Nerve RepairNerve Transection RepairPeripheral Nerve RegenerationRegeneration-promoting Signaling PathwaysRegenerative ProliferationSchwann Cell Proliferation
OBJECTIVE: Attenuation of the growth supportive environment within the distal nerve stump after delayed peripheral nerve repair profoundly limits nerve regeneration. Levels of the potent Schwann cell mitogen neuregulin and its receptor ErbB2 decline during this period, but the regenerative impact of this change is not completely understood. Herein, the ErbB2 receptor pathway is inhibited with the selective monoclonal antibody Herceptin (trastuzumab) to determine its significance in regulating acute and chronic regeneration in a rat hindlimb. METHODS: The common peroneal nerve of Sprague-Dawley rats was transected and repaired immediately or after 4 months of chronic denervation, followed by administration of Herceptin or saline solution. Regenerated motor and sensory neurons were counted using a retrograde tracer 1, 2, or 4, weeks after repair. Distal myelinated axon outgrowth after 4 weeks was quantified using histomorphometry. Immunofluorescent imaging was used to evaluate Schwann cell proliferation and epidermal growth factor receptor (EGFR) activation in the regenerating nerves. RESULTS: Herceptin administration increased the rate of motor and sensory neuron regeneration and the number of proliferating Schwann cells in the distal stump after the first week. Herceptin also increased the number of myelinated axons that regenerated 4 weeks after immediate and delayed repair. Reduced EGFR activation was observed using immunofluorescent imaging. INTERPRETATION: Inhibition of the ErbB2 receptor with Herceptin unexpectedly enhances nerve regeneration after acute and delayed nerve repair. This finding raises the possibility of using targeted molecular therapies to improve outcomes of peripheral nerve injuries. The mechanism may involve a novel inhibitory association between ErbB2 and EGFR. Ann Neurol 2016;80:112-126.
41
Estimation of nuclear population from microtome sections
M. Abercrombie · The Anatomical Record · 1946 · 4.4K citations
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Paul Carter, Leonard G. Presta, C Gorman et al. · Proceedings of the National Academy of Sciences · 1992 · 1.9K citations
José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations
Medicine, Oncology, Pharmacology +17
Axonal Neuregulin-1 Regulates Myelin Sheath Thickness
G. Michailov, Michael W. Sereda, Bastian G. Brinkmann et al. · Science · 2004 · 940 citations